NCT06314087View on ClinicalTrials.gov

Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE)

PHASE2RecruitingINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

August 16, 2026

Study Completion Date

August 31, 2026

Conditions
Advanced Tumors
Interventions
OTHER

Placebo + conventional treatment including radiotherapy

Placebo + conventional treatment including radiotherapy

COMBINATION_PRODUCT

Radiation: Radiation Therapy；Biological: Personalized tumor peptide vaccine

The peptide vaccine treatment will take 5 months as a treatment course until the treatment suspension event as stipulated in the plan occurred.

Trial Locations (2)

518000

RECRUITING

University of Hong Kong-Shenzhen Hospital, Shenzhen

Unknown

ENROLLING_BY_INVITATION

University of Hong Kong-Shenzhen Hospital, Shenzhen

All Listed Sponsors
lead

The University of Hong Kong-Shenzhen Hospital

OTHER